1. Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability". Issue 1 (6th September 2021) Authors: Arad, Nitzan; Kroetsch, Adam; McClellan, Mark Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 1(2022) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗